A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
Summary
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2022
Committee Review
Floor Vote
President
Introduced Jul 27, 2022
Last action Jul 27, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 27, 2022
Committee
Read twice and referred to the Committee on Finance.
upper
Jul 27, 2022
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4633
Scope: US
Hi! I can help you understand S 4633. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline